NCT07227662 Feasibility, Usability and Preliminary Efficacy of Home-based FES Fro Adhesive Capsulitis
| NCT ID | NCT07227662 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Maryland, Baltimore |
| Condition | Shoulder Adhesive Capsulitis |
| Study Type | INTERVENTIONAL |
| Enrollment | 10 participants |
| Start Date | 2026-06-01 |
| Primary Completion | 2026-12-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 10 participants in total. It began in 2026-06-01 with a primary completion date of 2026-12-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to investigate the feasibility, usability and preliminary efficacy of a home-based Functional Electrical Stimulation(FES) in individuals with shoulder adhesive capsulitis. The main question it aims to answer is if combining home-based FES to usual therapy at the clinic will improve pain and improve function of the impaired shoulder.
Eligibility Criteria
Inclusion Criteria: 1. Age \> 18 years 2. Individuals diagnosed with shoulder adhesive capsulitis 3. Shoulder pain, limited shoulder mobility for more than 4 weeks, normal shoulder x-ray findings, and normal neurological exam 4. Can tolerate electrical stimulation Exclusion Criteria: 1. Presence of shoulder tumors or bone lesions 2. History of shoulder fracture or subluxation 3. History of shoulder surgery 4. Severe osteoporosis, 5. Rheumatic disease 6. Radiating pain from cervical radiculopathy 7. Participation in other clinical trial, and/or intraarticular steroid injections within 6 weeks
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07227662 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Shoulder Adhesive Capsulitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07227662 currently recruiting?
Yes, NCT07227662 is actively recruiting participants. Contact the research team at sanjana.rao@som.umaryland.edu for enrollment information.
Where is the NCT07227662 trial being conducted?
This trial is being conducted at Baltimore, United States.
Who is sponsoring the NCT07227662 clinical trial?
NCT07227662 is sponsored by University of Maryland, Baltimore. The trial plans to enroll 10 participants.